PL377292A1 - Ulepszony sposób wytwarzania 1,3-podstawionych indenów - Google Patents

Ulepszony sposób wytwarzania 1,3-podstawionych indenów

Info

Publication number
PL377292A1
PL377292A1 PL377292A PL37729203A PL377292A1 PL 377292 A1 PL377292 A1 PL 377292A1 PL 377292 A PL377292 A PL 377292A PL 37729203 A PL37729203 A PL 37729203A PL 377292 A1 PL377292 A1 PL 377292A1
Authority
PL
Poland
Prior art keywords
preparation
improved process
substituted indenes
indenes
substituted
Prior art date
Application number
PL377292A
Other languages
English (en)
Inventor
Robert Eugene Handfield Jr.
Philip James Johnson
Peter Robert Rose
Timothy James Norman Watson
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of PL377292A1 publication Critical patent/PL377292A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Circuit Arrangements For Discharge Lamps (AREA)
PL377292A 2002-11-25 2003-11-12 Ulepszony sposób wytwarzania 1,3-podstawionych indenów PL377292A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42902902P 2002-11-25 2002-11-25

Publications (1)

Publication Number Publication Date
PL377292A1 true PL377292A1 (pl) 2006-01-23

Family

ID=32393492

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377292A PL377292A1 (pl) 2002-11-25 2003-11-12 Ulepszony sposób wytwarzania 1,3-podstawionych indenów

Country Status (16)

Country Link
US (1) US7285686B2 (pl)
EP (1) EP1567483A1 (pl)
JP (1) JP2006507342A (pl)
KR (1) KR100655848B1 (pl)
CN (1) CN1714075A (pl)
AR (1) AR042205A1 (pl)
AU (1) AU2003278510B8 (pl)
BR (1) BR0316482A (pl)
CA (1) CA2511762A1 (pl)
MX (1) MXPA05005517A (pl)
PL (1) PL377292A1 (pl)
RS (1) RS20050393A (pl)
RU (1) RU2284319C2 (pl)
TW (1) TWI245756B (pl)
WO (1) WO2004048318A1 (pl)
ZA (1) ZA200503190B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504852A (ja) 2005-08-11 2009-02-05 ユニバーシティ オブ マサチューセッツ ロウエル オレフィンおよび保護または非保護のヒドロキシスチレン単位を含む共重合体を形成するための方法
WO2009143347A2 (en) 2008-05-22 2009-11-26 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
US20090318695A1 (en) * 2008-06-19 2009-12-24 Vinod Kumar Kansal Processes for the preparation of varenicline and intermediates thereof
WO2010005643A1 (en) * 2008-07-10 2010-01-14 Teva Pharmaceutical Industries Ltd. Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt
WO2010151524A1 (en) 2009-06-22 2010-12-29 Teva Pharmaceutical Industries Ltd Solid states forms of varenicline salts and processes for preparation thereof
WO2016164744A1 (en) * 2015-04-08 2016-10-13 Kemin Industries, Inc. Protective action of lutein against blue light on human skin cell lines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605610B1 (en) 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
CN1324013C (zh) 1997-12-31 2007-07-04 辉瑞产品公司 芳基稠合氮杂多环化合物
HUP0303811A3 (en) * 2001-04-20 2008-05-28 Pfizer Prod Inc Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
CA2502443A1 (en) 2002-11-20 2004-06-03 Pfizer Products Inc. A method for preparing indan-1,3-dicarboxylic acid
RU2291862C2 (ru) 2003-01-15 2007-01-20 Пфайзер Продактс Инк. Способ получения арилконденсированных полициклических лактамов

Also Published As

Publication number Publication date
MXPA05005517A (es) 2005-07-25
US7285686B2 (en) 2007-10-23
KR20050087801A (ko) 2005-08-31
BR0316482A (pt) 2005-10-11
AR042205A1 (es) 2005-06-15
EP1567483A1 (en) 2005-08-31
ZA200503190B (en) 2006-07-26
AU2003278510B8 (en) 2008-07-10
RU2284319C2 (ru) 2006-09-27
CA2511762A1 (en) 2004-06-10
US20050004379A1 (en) 2005-01-06
RS20050393A (en) 2007-12-31
TWI245756B (en) 2005-12-21
RU2005115881A (ru) 2006-02-27
WO2004048318A8 (en) 2005-05-12
TW200413301A (en) 2004-08-01
KR100655848B1 (ko) 2006-12-11
CN1714075A (zh) 2005-12-28
JP2006507342A (ja) 2006-03-02
AU2003278510B2 (en) 2008-06-05
AU2003278510A1 (en) 2004-06-18
WO2004048318A1 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HK1078087A1 (en) Process for the preparation of (s,s)-cis-2-benzhydryl-3- benzylaminoquinuclidine
HK1099274A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoropropane and 1,1,1,2,3- pentafluoropropane
HK1044338A1 (en) 5-Pyridyl-1, 3-azole compounds, process for producing the same and use thereof
AU2003265589A8 (en) Process for the preparation of 1,1,1,2,2-pentafluoroethane
MXPA03009527A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO.
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
PL377292A1 (pl) Ulepszony sposób wytwarzania 1,3-podstawionych indenów
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
EG23417A (en) Process for the preparation 7 a-methylsteroids.
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2003269482A1 (en) Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
HK1041606B (zh) N，n'-羰基雙內酰胺的製備方法
AUPS260702A0 (en) Process for the preparation of 2,6-difluoropurines
AU2002241192A8 (en) Process for the preparation of 1-(2,6,6-trimethyl-2-cyclohexene-1-yl)-but-2-ene-1-one
AU2003284212A8 (en) Process for the preparation of (s,s)-cis-2-phenyl-3-aminopiperidine

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)